Sera Prognostics schedules conference call, webcast for quarterly results updatePUBT·Jul 29 at 03:15 PMSERA+1.96%
PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CAREUnusual Whales·Jul 9 at 03:07 PMSERA+1.96%
Sera Prognostics announces new PRIME subgroup analysis publication on PreTRM test-guided carePUBT·Jul 9 at 03:07 PMSERA+1.96%
Sera Prognostics director Mark Christopher Capone files initial beneficial ownership statementPUBT·Jul 1 at 03:11 PMSERA+1.96%
Sera Prognostics names former Myriad Genetics CEO Mark Capone to boardPUBT·Jun 30 at 03:06 PMSERA+1.96%
SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORSPR Newswire·Jun 30 at 03:05 PMSERA+1.96%
Sera Prognostics joins ARPA-H award worth up to $10.4 million for point-of-care birth diagnosticPUBT·Jun 24 at 03:06 PMSERA+1.96%ALGM-0.83%
SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTHUnusual Whales·Jun 24 at 03:06 PMSERA+1.96%
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCYUnusual Whales·Jun 23 at 03:07 PMSERA+1.96%
Sera Prognostics welcomes Illinois move to expand Medicaid coverage for preterm birth blood testPUBT·Jun 23 at 03:05 PMSERA+1.96%
Top Executives Quietly Unload Sera Prognostics Shares in Back-to-Back MovesTip Ranks·Jun 10 at 09:09 PMSERA+1.96%
